Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients

Kidney International

Volumn 72, Issue 9, 2007, Pages 1138-1148

  Lim, W H ^a,b   Kireta, S ^a   Leedham, E ^a   Russ, G R ^a,b   Coates, P T ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Chronic renal failure; Dendritic cells; Hemodialysis; Monocyte; Uremia

Indexed keywords

INTERLEUKIN 12P70; URIC ACID;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOCYTOSIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNE FUNCTION TEST; IMMUNOMAGNETIC SEPARATION; IN VITRO STUDY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UREMIA;

ADULT; BLOOD PROTEINS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; INTERLEUKIN-12; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MONOCYTES; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; UREA; UREMIA;

EID: 35349004180     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002425     Document Type: Article

References (39)

1. Fearon D, Locksley R. The instructive role of innate immunity in the acquired immune response. Science 1996; 272: 50-53.
2. Iida T, Umezawa K, Tanaka K et al. Polymorphonuclear cells in chronic hemodialysis patients have intact phagocytic and impaired bactericidal activities. Nephron 1997; 75: 41-47.
3. Vanholder R, Ringoir S. Polymorphonuclear cell function and infection in dialysis. Kidney Int 1992; 38(Suppl): S91-S95.
4. Girndt M, Kohler H, Schiedhelm-Weick E et al. T-cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathway. Kidney Int 1993; 44: 359-365.
5. Gerez L, Madar L, Shkolnik T et al. Regulation of interleukin-2 and interferon-gamma gene expression in renal failure. Kidney Int 1991; 40: 266-272.
6. No authors listed. U.S. Renal Data System: USRDS 1998 annual data report. Am J Kidney Dis 1998; 32(Suppl): S150-S162.
7. McDonald S. Deaths. In: Russ G (ed). Australia and New Zealand Dialysis and Transplant Registry. Australia and New Zealand Transplant Registry: Adelaide, South Australia, 2003, p 19.
8. Kohler H, Arnold W, Renschin G et al. Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 1984; 25: 124-128.
9. Coates PTH, Wilson R, Patrick G et al. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Therap 2001; 23: 392-403.
10. Hasselink D, Betjes M, Verkade M et al. The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells. Nephrol Dial Transplant 2005; 20: 1868-1873.
11. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Ann Rev Immunol 2000; 18: 767-811.
12. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-251.
13. Coates PTH, Thomson AW. Dendritic cells, tolerance induction and transplant outcome. Am J Transplant 2002; 2: 299-307.
14. Inaba K, Inaba M, Naito M et al. Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 1993; 23: 1595-1601.
15. Hsu F, Benike C, Fagoni F et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med 1996; 2: 52-58.
16. Leon B, Lopez-Bravo M, Ardavin C. Monocyte-derived dendritic cells. Semin Immunol 2005; 17: 313-318.
17. Bozza S, Perruccio K, Montagnoli C et al. A dendritic cell vaccine against invasive aspergillosis in allogenic hematopoietic transplantation. Blood 2003; 102: 3807-3814.
18. Richards J, Ampel N, Lake D. Reversal of coccidioidal anergy in vitro by dendritic cells from patients with disseminated coccidioidomycosis. J Immunol 2002; 169: 2020-2025.
19. Shao C, Qu J, He L et al. Dendritic cells transduced with an adenovirus vector encoding interleukin-12 are a potent vaccine for invasive pulmonary aspergillosis. Genes Immun 2005; 6: 103-114.
20. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109-1118.
21. Ardavin C, Martinez del Hoyo G, Martin P et al. Origin and differentiation of dendritic cells. Trends Immunol 2001; 22: 691-700.
22. Lim WH, Kireta S, Russ G et al. Renal transplantation reverses functional deficiencies in circulating dendritic cell subsets in chronic renal failure patients. Transplantation 2006; 81: 160-168.
23. Langrish C, McKenzie B, Wilson N et al. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 2004; 202: 96-105.
24. Kang B, Kim E, Kim T. Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells. Cell Signal 2005; 17: 665-673.
25. Ishizuka T, Nitta K, Yokoyama T et al. Increased serum levels of interleukin-12 may be associated with Th1 differentiation in hemodialysis patients. Nephron 2002; 90: 503-504.
26. Sester U, Sester M, Hauk M et al. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant 2000; 15: 1217-1223.
27. Heidenreich S, Schmidt M, Bachmann J et al. Apoptosis of monocyte cultured from long-term hemodialysis patients. Kidney Int 1996; 49: 792-799.
28. Meier P, Dayer E, Blanc E et al. Early T-cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 204-212.
29. Nagayama H, Sato K, Kawasaki H et al. IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells. J Immunol 2000; 165: 59-66.
30. Masuda M, Komiyama Y, Murakami T et al. Decrease of polymorphonuclear leukocyte membrane fluidity in uremic patients on hemodialysis. Nephron 1990; 54: 36-41.
31. Vanholder R, De Smet R, Jacobs V et al. Uraemic toxic retention solutes depress polymorphonuclear response to phagocytosis. Nephrol Dial Transplant 1994; 9: 1271-1278.
32. Jorstad S, Viken K. Inhibitory effects of plasma from uraemic patients on human mononuclear phagocytes cultured in vitro. Acta Pathol Microbiol Scand (C) 1977; 85: 169-177.
33. Jorstad S, Kvernes S. Uraemic toxins of high molecular weight inhibiting human mononuclear phagocytes cultured in vitro. Acta Pathol Microbiol Scand (C) 1978; 86C: 221-226.
34. Porter C, Burden R, Morgan A et al. Impaired polymorphonuclear neutrophil function in end-stage renal failure and its correction by continuous ambulatory peritoneal dialysis. Nephron 1995; 71: 133-137.
35. Girndt M, Sester M, Sester U et al. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int 2001; 59: 1382-1389.
36. Cockcroft D, Gault M. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
37. Hackstein H, Morelli AE, Larregina AT et al. Aspirin inhibits the in vivo maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J Immunol 2001; 165: 7053-7062.
38. Miltenyi S, Schmitz J. High gradient magnetic cell sorting. In: Radbruch A (ed). Flow Cytometry and Cell Sorting. Springer-Verlag: Berlin, 1999 p 218.
39. Coates PTH, Krishnan R, Kireta S et al. Human myeloid dendritic cells transduced with an adenoviral interleukin 10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice. Gene Therapy 2001; 8: 1224-1233.